Inflammation in end-stage renal disease--what have we learned in 10 years?
about
Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic ReviewThe evolution of endothelial regulatory paradigms in cancer biology and vascular repairThe Gut as a Source of Inflammation in Chronic Kidney DiseasePredictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start HemodialysisCare of undocumented-uninsured immigrants in a large urban dialysis unit.Seroprevalence of a "new" bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patientsMicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney DiseaseIL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survivalA novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?Effect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats.Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).Role of Growth Hormone Deficiency and Treatment in Chronic Kidney DiseaseDelta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patientsOxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney diseaseEffect of uremia on structure and function of immune system.Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseProlactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.Candidate Gene Analysis of Mortality in Dialysis PatientsLow resistin level is associated with poor hospitalization-free survival in hemodialysis patients.Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients.Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis.High cardiovascular event rates occur within the first weeks of starting hemodialysisLevels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients.Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment.Cytokine profiles in peritoneal dialysis effluent predicts the peritoneal solute transport rate in continuous ambulatory peritoneal dialysis patients.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Platelet to Lymphocyte Percentage Ratio Is Associated With Brachial-Ankle Pulse Wave Velocity in Hemodialysis.Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.Inflammatory factors and exercise in chronic kidney disease.Evidence of perturbed germinal center dynamics, but preserved antibody diversity, in end-stage renal disease.Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.A comparative study of blood endotoxin detection in haemodialysis patientsInterleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.
P2860
Q26752715-49AA686C-D0A4-42CA-A1F0-1A3FFDF74657Q26822678-4B7705E8-1817-4CF3-BDC6-64724EBCEDE7Q28081781-9B699C72-57FF-4DD1-ADED-1703017098EAQ28468444-878DE4D3-9870-4B7C-8809-D0BF7BEB2D7FQ31095229-D02C046E-635A-410B-99DC-3CDDC1FEA931Q33564650-C8A94CF0-FFE4-4B8E-8B09-9BF39C6498FAQ33652408-FEBDDF17-452F-4534-8845-C92D4CEC2E29Q33797359-7D684123-FCA1-4695-AC41-DF4BAD8227BEQ33916132-DE079FA3-1332-49E8-BAC0-F0026CD445C1Q34328779-D6A8D665-136A-45E6-B62F-42D31645FAC1Q34577095-18C75AB9-6C39-4B74-B7F4-D008C9DB559FQ34713240-ED7E4C5D-51F4-45AC-84B3-FB87022A2C2FQ34751855-46AD5EF7-90A4-4E26-A48D-E59FEF94C9DDQ34988670-3D60F441-3987-4AA3-885C-B37D9BE7B80FQ35149805-7411E866-407D-45D2-8AEE-6976F2BFF3D5Q35227582-A69113F8-CB3D-45B0-93DD-0ABBA4043E92Q35524790-F68A9D8B-BB4E-41FC-BCE2-817D14612D22Q35530832-85C9ED67-F318-40E2-A7BE-4D80766A8B2EQ35635884-C8B34E96-86B3-4EFF-9100-B15FC04C56E9Q35664554-803EF12E-2564-483C-BBEA-0BAA03AC2474Q35758553-199ADB7E-9301-4483-B51D-971A90585E9AQ35847012-B848B0E2-8BF3-4A82-AB2A-1CD9472BEEF2Q35859220-281D3283-220B-4822-A02B-54C3EC82D005Q35904435-A07B2911-2D8B-4D5D-BDA3-20548D6437EAQ36156630-CC1CCAAA-4DE3-4AD3-A9B4-26F7D77C1DF5Q36169427-EA9A0B58-F46B-4BA8-A073-7B67AA7476D7Q36170858-AD7DE8BD-FA9B-45DB-84D2-F5CC1146F9F5Q36301002-3DAFC56D-6042-421D-926B-4DD027DCB4C0Q36375537-5CBC99B1-46F1-4421-98BF-BB940227B463Q36437245-2F1CCE39-93F4-4C93-8B87-8CC22D9C2F1AQ36492738-FF453D6B-1E24-4FEF-8E78-E6C3CFBFBA5BQ36533057-06FCF807-9DA9-49FC-9B0F-A00542DAEA9EQ36580980-B29D7CEB-F842-4DDB-9BF5-DFF2EDFF8381Q36838097-CAA5BCC4-F7E9-413C-A5FA-463D1E9FE909Q36849215-3E657AB8-6909-49BB-91CA-791891AFF2B1Q36882794-DA6FD885-58C6-4701-8E40-DF1F94DABEDFQ36933665-25CF8B2B-2CDE-4A76-98BA-A9348B2042DCQ36940342-60884348-0024-43E6-A6A8-BA0D45C0E288Q37139884-73D90DF7-EA8A-4DD4-9BE8-1CF9198893C9Q37346569-9BCA33AF-5AD6-4DE1-A44C-F2700EF8A920
P2860
Inflammation in end-stage renal disease--what have we learned in 10 years?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation in end-stage renal disease--what have we learned in 10 years?
@en
Inflammation in end-stage renal disease--what have we learned in 10 years?
@nl
type
label
Inflammation in end-stage renal disease--what have we learned in 10 years?
@en
Inflammation in end-stage renal disease--what have we learned in 10 years?
@nl
prefLabel
Inflammation in end-stage renal disease--what have we learned in 10 years?
@en
Inflammation in end-stage renal disease--what have we learned in 10 years?
@nl
P2860
P1433
P1476
Inflammation in end-stage renal disease--what have we learned in 10 years?
@en
P2860
P304
P356
10.1111/J.1525-139X.2010.00784.X
P577
2010-09-01T00:00:00Z